Amolyt Pharma Transaction

Convertible Investment New Security Issue in France, Europe

Transaction Details

Name:Amolyt Pharma
Amount:Available on swfi.com
Announced At:09/16/2021
Closed At:09/16/2021
RegionEurope
Country:France
Type:New Security Issue
Security Type:Convertible Preferred Stock
Investment Type:Convertible
SectorHealthcare
Industry:Biotechnology
Summary:Available

Buyers

Entity 1
Development Bank in France		Stake
Available on swfi.com